Interim analysis of the “shutter speed” MRI model to detect clinically significant prostate cancer.

Artificial intelligence–derived tumor volume from baseline MRI and postprostatectomy outcomes following neoadjuvant hormonal therapy for patients with high-risk prostate cancer.

Study Finds New Blood Test Predicts Prognosis for Advanced Prostate Cancer Patients Dec ... New Prostate Biopsy Technique Lowers Infection Risk Sep. 19, 2024 — A multi-institutional clinical ...

Population A hypothetical cohort of 1000 men with suspected prostate cancer. Interventions mpMRI and, if positive, MRI-targeted biopsy compared with TRUS-guided biopsy in all men. Outcome measures We ...

It's common for healthcare professionals to order biopsies for patients whom they suspect may have prostate cancer. A biopsy doesn't just rule out prostate cancer or show its presence, though.

ensuring that treatment options are tailored to the patient's genomic profile. In addition to these well-established markers, prostate-specific membrane antigen [PSMA], has emerged as a critical ...

When introducing the study to eligible patients, we describe it as a research study about how doctors and patients talk about prostate biopsy results and next steps. There can be complicated ...

I have recently been diagnosed with prostate cancer. One blood test showed a PSA level of 13 ng/mL, and a second was 17 ng/mL. So, I underwent a biopsy, which showed adenocarcinoma with a Gleason ...